Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Ana Gleisner to Carcinoma, Hepatocellular

This is a "connection" page, showing publications Ana Gleisner has written about Carcinoma, Hepatocellular.

 
Connection Strength
  
 
 
6.321
  
  1. Ziogas IA, Gleisner AL. Resection Versus Transplant for Hepatocellular Carcinoma: How to Offer the Best Modality. Surg Clin North Am. 2024 Feb; 104(1):113-127.
    View in: PubMed
    Score: 0.611
  2. Baldo A, Akabane M, Kawashima J, Endo Y, Chatzipanagiotou OP, Sahara K, Ruzzenente A, Lesurtel M, Bauer TW, Marques HP, Martel G, Popescu I, Weiss MJ, Kitago M, Poultsides G, Sasaki K, Maithel SK, Hugh T, Gleisner A, Aucejo F, Pulitano C, Shen F, Koerkamp BG, Endo I, Spolverato G, Pawlik TM. Risk-adjusted cumulative sum (RA-CUSUM) method for real time monitoring of surgical units performance. HPB (Oxford). 2026 Jul; 28(7):987-995.
    View in: PubMed
    Score: 0.183
  3. Endo Y, Kawashima J, Chatzipanagiotou O, Woldesenbet S, Aucejo F, Marques HP, Lam V, Lesurtel M, Popescu I, Weiss M, Martel G, Poultsides GA, Ruzzenente A, Endo I, Gleisner A, Shen F, Pawlik TM. Machine learning-based clustering differentiates bilateral hepatocellular carcinoma characteristics and prognosis. Surgery. 2026 Jun; 194:110186.
    View in: PubMed
    Score: 0.182
  4. Chatzipanagiotou OP, Catalano G, Mujtaba K, Kawashima J, Altaf A, Cauchy F, Aucejo F, Marques HP, Lam V, Hugh T, Popescu I, Kitago M, Weiss M, Martel G, Ratti F, Poultsides GA, Ruzzenente A, Endo I, Gleisner A, Pawlik TM. Perioperative changes in ALBI and platelets (CAP): association with postoperative complications among patients undergoing surgery for hepatocellular carcinoma. HPB (Oxford). 2026 Mar; 28(3):389-398.
    View in: PubMed
    Score: 0.178
  5. Akabane M, Baldo A, Kawashima J, Woldesenbet S, Lesurty M, Aucejo F, Popescu I, Kitago M, Martel G, Ratti F, Aldrighetti L, Poultsides GA, Imaoka Y, Ruzzenente A, Endo I, Gleisner A, Marques HP, Lam V, Hugh T, Bhimani N, Shen F, Pawlik TM. Beyond the composite: Differential impact of albumin and bilirubin relative to tumor burden in HCC. Eur J Surg Oncol. 2026 Feb; 52(2):111309.
    View in: PubMed
    Score: 0.177
  6. Akabane M, Kawashima J, Altaf A, Woldesenbet S, Cauchy F, Aucejo F, Popescu I, Kitago M, Martel G, Ratti F, Aldrighetti L, Poultsides GA, Imaoka Y, Ruzzenente A, Endo I, Gleisner A, Marques HP, Lam V, Hugh T, Bhimani N, Shen F, Pawlik TM. Minimally invasive surgery for hepatocellular carcinoma: evolving trade-offs of patient selection and recurrence risk. J Gastrointest Surg. 2026 01; 30(1):102272.
    View in: PubMed
    Score: 0.177
  7. Akabane M, Kawashima J, Woldesenbet S, Thammachack R, Cauchy F, Aucejo F, Popescu I, Kitago M, Martel G, Ratti F, Aldrighetti L, Poultsides GA, Imaoka Y, Ruzzenente A, Endo I, Gleisner A, Marques HP, Lam V, Hugh T, Bhimani N, Shen F, Pawlik TM. The surgical burden score: a novel continuous metric to predict postoperative complications after hepatectomy for hepatocellular carcinoma. HPB (Oxford). 2025 Nov; 27(11):1445-1454.
    View in: PubMed
    Score: 0.174
  8. Akabane M, Kawashima J, Woldesenbet S, Cauchy F, Aucejo F, Popescu I, Kitago M, Martel G, Ratti F, Aldrighetti L, Poultsides GA, Imaoka Y, Ruzzenente A, Endo I, Gleisner A, Marques HP, Lam V, Hugh T, Bhimani N, Shen F, Pawlik TM. International validation of a natural-killer-cell-based model to predict recurrence-free survival in hepatocellular carcinoma. HPB (Oxford). 2025 Oct; 27(10):1259-1269.
    View in: PubMed
    Score: 0.173
  9. Kawashima J, Endo Y, Khalil M, Woldesenbet S, Akabane M, Ruzzenente A, Ratti F, Marques H, Oliveira S, Balaia J, Cauchy F, Lam V, Poultsides G, Kitago M, Popescu I, Martel G, Gleisner A, Hugh TJ, Aldrighetti L, Endo I, Pawlik TM. Development and validation of a preoperative risk prediction model for severe complications and very early recurrence after liver resection for hepatocellular carcinoma. Surgery. 2025 Sep; 185:109527.
    View in: PubMed
    Score: 0.172
  10. Akabane M, Kawashima J, Woldesenbet S, Lee GR, Cauchy F, Aucejo F, Popescu I, Kitago M, Martel G, Ratti F, Aldrighetti L, Poultsides GA, Imaoka Y, Ruzzenente A, Endo I, Gleisner A, Marques HP, Lam V, Hugh T, Bhimani N, Shen F, Pawlik TM. Distinct patterns of late recurrence in long-term hepatocellular carcinoma survivors. J Gastrointest Surg. 2025 09; 29(9):102135.
    View in: PubMed
    Score: 0.172
  11. Altaf A, Baldo A, Khalil M, Rashid Z, Akabane M, Zindani S, Sarfraz A, Ruzzenente A, Aldrighetti L, Bauer TW, Marques HP, Martel G, Popescu I, Weiss MJ, Kitago M, Poultsides G, Maithel SK, Lam V, Hugh T, Gleisner A, Shen F, Cauchy F, Koerkamp BG, Endo I, Pawlik TM. Lymphocyte-C-Reactive Protein Ratio: Impact on Prognosis of Patients Following Resection of Primary Liver Cancer. World J Surg. 2025 Aug; 49(8):2195-2206.
    View in: PubMed
    Score: 0.172
  12. Akabane M, Kawashima J, Altaf A, Woldesenbet S, Cauchy F, Aucejo F, Popescu I, Kitago M, Martel G, Ratti F, Aldrighetti L, Poultsides GA, Imaoka Y, Ruzzenente A, Endo I, Gleisner A, Marques HP, Oliveira S, Balaia J, Lam V, Hugh T, Bhimani N, Shen F, Pawlik TM. Unraveling the obesity paradox in hepatocellular carcinoma: relative role of elevated body mass index on detrimental effects of postoperative complications. HPB (Oxford). 2025 Aug; 27(8):1103-1112.
    View in: PubMed
    Score: 0.171
  13. Kawashima J, Endo Y, Khalil M, Woldesenbet S, Akabane M, Ruzzenente A, Ratti F, Marques H, Oliveira S, Balaia J, Cauchy F, Lam V, Poultsides G, Kitago M, Popescu I, Martel G, Gleisner A, Hugh TJ, Aldrighetti L, Endo I, Pawlik TM. Impact of Anatomical Resection on Non-transplantable Recurrence Among Patients with Hepatocellular Carcinoma: An International Multicenter Inverse Probability of Treatment Weighting Analysis. Ann Surg Oncol. 2025 Sep; 32(9):6243-6253.
    View in: PubMed
    Score: 0.171
  14. Kawashima J, Akabane M, Khalil M, Woldesenbet S, Endo Y, Sahara K, Ruzzenente A, Ratti F, Marques HP, Oliveira S, Balaia J, Cauchy F, Lam V, Poultsides GA, Kitago M, Popescu I, Martel G, Gleisner A, Hugh T, Weiss M, Aucejo F, Aldrighetti L, Endo I, Pawlik TM. Model of End-Stage Liver Disease-alpha-fetoprotein-tumor burden (MELD-AFP-TBS) score to stratify prognosis after liver resection for hepatocellular carcinoma. Surgery. 2025 Jul; 183:109388.
    View in: PubMed
    Score: 0.171
  15. Akabane M, Kawashima J, Altaf A, Woldesenbet S, Cauchy F, Aucejo F, Popescu I, Kitago M, Martel G, Ratti F, Aldrighetti L, Poultsides GA, Imaoka Y, Ruzzenente A, Endo I, Gleisner A, Marques HP, Oliveira S, Balaia J, Lam V, Hugh T, Bhimani N, Shen F, Pawlik TM. Enhancing Recurrence-Free Survival Prediction in Hepatocellular Carcinoma: A Time-Updated Model Incorporating Tumor Burden and AFP Dynamics. Ann Surg Oncol. 2025 Aug; 32(8):5648-5656.
    View in: PubMed
    Score: 0.170
  16. Catalano G, Alaimo L, Chatzipanagiotou OP, Ruzzenente A, Aucejo F, Marques HP, Lam V, Hugh T, Bhimani N, Kitago M, Endo I, Martel G, Popescu I, Cauchy F, Poultsides GA, Gleisner A, Pawlik TM. Analysis of a modified surgical desirability of outcome ranking (mDOOR) among patients undergoing surgery for Hepatocellular carcinoma. HPB (Oxford). 2025 Jun; 27(6):799-806.
    View in: PubMed
    Score: 0.169
  17. Catalano G, Alaimo L, Chatzipanagiotou OP, Ruzzenente A, Ratti F, Aldrighetti L, Marques HP, Cauchy F, Lam V, Poultsides GA, Hugh T, Popescu I, Alexandrescu S, Martel G, Kitago M, Endo I, Gleisner A, Shen F, Pawlik TM. Predicting the complexity of minimally invasive liver resection for hepatocellular carcinoma using machine learning. HPB (Oxford). 2025 Jun; 27(6):807-815.
    View in: PubMed
    Score: 0.169
  18. Akabane M, Kawashima J, Altaf A, Woldesenbet S, Cauchy F, Aucejo F, Popescu I, Kitago M, Martel G, Ratti F, Aldrighetti L, Poultsides GA, Imaoka Y, Ruzzenente A, Endo I, Gleisner A, Marques HP, Lam V, Hugh T, Bhimani N, Shen F, Pawlik TM. Dynamic ALBI score and FIB-4 index trends to predict complications after resection of hepatocellular carcinoma: A K-means clustering approach. Eur J Surg Oncol. 2025 06; 51(6):109723.
    View in: PubMed
    Score: 0.168
  19. Akabane M, Kawashima J, Altaf A, Woldesenbet S, Cauchy F, Aucejo F, Popescu I, Kitago M, Martel G, Ratti F, Aldrighetti L, Poultsides GA, Imaoka Y, Ruzzenente A, Endo I, Gleisner A, Marques HP, Lam V, Hugh T, Bhimani N, Shen F, Pawlik TM. Impact of disparity between imaging and pathological tumor size on cancer-specific prognosis among patients with hepatocellular carcinoma. Eur J Surg Oncol. 2025 06; 51(6):109683.
    View in: PubMed
    Score: 0.168
  20. Akabane M, Kawashima J, Altaf A, Woldesenbet S, Cauchy F, Aucejo F, Popescu I, Kitago M, Martel G, Ratti F, Aldrighetti L, Poultsides GA, Imaoka Y, Ruzzenente A, Endo I, Gleisner A, Marques HP, Lam V, Hugh T, Bhimani N, Shen F, Pawlik TM. Development and validation of the albumin-bilirubin gamma-glutamyl transferase score for enhanced prognostic accuracy after hepatocellular carcinoma resection. J Gastrointest Surg. 2025 04; 29(4):101984.
    View in: PubMed
    Score: 0.168
  21. Kawashima J, Akabane M, Endo Y, Woldesenbet S, Khalil M, Sahara K, Ruzzenente A, Aldrighetti L, Bauer TW, Marques HP, Lopes R, Oliveira S, Martel G, Popescu I, Weiss MJ, Kitago M, Poultsides G, Sasaki K, Maithel SK, Hugh T, Gleisner A, Aucejo F, Pulitano C, Shen F, Cauchy F, Groot Koerkamp B, Endo I, Pawlik TM. A Composite Endpoint of Liver Surgery (CELS): Development and Validation of a Clinically Relevant Endpoint Requiring a Smaller Sample Size. Ann Surg Oncol. 2025 May; 32(5):3505-3515.
    View in: PubMed
    Score: 0.168
  22. Altaf A, Khalil M, Akabane M, Rashid Z, Kawashima J, Zindani S, Ruzzenente A, Ratti F, Marques H, Cauchy F, Lam V, Poultsides G, Aucejo F, Kitago M, Popescu I, Martel G, Gleisner A, Bauer TW, Hugh T, Bhimani N, Shen F, Endo I, Pawlik TM. Up-front resection for hepatocellular carcinoma: Assessing futility in the preoperative setting. Eur J Surg Oncol. 2025 05; 51(5):109594.
    View in: PubMed
    Score: 0.167
  23. Altaf A, Munir MM, Khan MMM, Rashid Z, Khalil M, Guglielmi A, Ratti F, Aldrighetti L, Bauer TW, Marques HP, Martel G, Alexandrescu S, Weiss MJ, Kitago M, Poultsides G, Maithel SK, Pulitano C, Lam V, Popescu I, Gleisner A, Hugh T, Shen F, Cauchy F, Koerkamp BG, Endo I, Pawlik TM. Machine learning based prediction model for bile leak following hepatectomy for liver cancer. HPB (Oxford). 2025 Apr; 27(4):489-501.
    View in: PubMed
    Score: 0.166
  24. Akabane M, Kawashima J, Woldesenbet S, Altaf A, Cauchy F, Aucejo F, Popescu I, Kitago M, Martel G, Ratti F, Aldrighetti L, Poultsides GA, Imaoka Y, Ruzzenente A, Endo I, Gleisner A, Marques HP, Lam V, Hugh T, Bhimani N, Shen F, Pawlik TM. Analyzing the interaction between time to surgery and tumor burden score in hepatocellular carcinoma. J Gastrointest Surg. 2025 02; 29(2):101903.
    View in: PubMed
    Score: 0.166
  25. Endo Y, Tsilimigras DI, Munir MM, Woldesenbet S, Guglielmi A, Ratti F, Marques HP, Cauchy F, Lam V, Poultsides GA, Kitago M, Alexandrescu S, Popescu I, Martel G, Gleisner A, Hugh T, Aldrighetti L, Shen F, Endo I, Pawlik TM. Machine learning models including preoperative and postoperative albumin-bilirubin score: short-term outcomes among patients with hepatocellular carcinoma. HPB (Oxford). 2024 Nov; 26(11):1369-1378.
    View in: PubMed
    Score: 0.162
  26. Altaf A, Endo Y, Munir MM, Khan MMM, Rashid Z, Khalil M, Guglielmi A, Ratti F, Marques H, Cauchy F, Lam V, Poultsides G, Kitago M, Popescu I, Martel G, Gleisner A, Hugh T, Shen F, Endo I, Pawlik TM. Impact of an artificial intelligence based model to predict non-transplantable recurrence among patients with hepatocellular carcinoma. HPB (Oxford). 2024 08; 26(8):1040-1050.
    View in: PubMed
    Score: 0.160
  27. Endo Y, Tsilimigras DI, Munir MM, Woldesenbet S, Yang J, Guglielmi A, Ratti F, Marques HP, Cauchy F, Lam V, Poultsides GA, Kitago M, Popescu I, Alexandrescu S, Martel G, Gleisner A, Hugh T, Aldrighetti L, Shen F, Endo I, Pawlik TM. Prognostic significance of postoperative complications for patients with hepatocellular carcinoma relative to alpha-feto protein and tumor burden score. HPB (Oxford). 2024 08; 26(8):998-1006.
    View in: PubMed
    Score: 0.159
  28. Endo Y, Tsilimigras DI, Munir MM, Woldesenbet S, Yang J, Katayama E, Guglielmi A, Ratti F, Marques HP, Cauchy F, Lam V, Poultsides GA, Kitago M, Popescu I, Alexandrescu S, Martel G, Gleisner A, Hugh T, Aldrighetti L, Shen F, Endo I, Pawlik TM. Textbook outcome in liver surgery: open vs minimally invasive hepatectomy among patients with hepatocellular carcinoma. J Gastrointest Surg. 2024 04; 28(4):417-424.
    View in: PubMed
    Score: 0.157
  29. Endo Y, Tsilimigras DI, Woldesenbet S, Marques HP, Cauchy F, Weiss M, Bauer TW, Poultsides GA, Maithel SK, Kitago M, Alexandrescu S, Martel G, Guglielmi A, Pulitano C, Gleisner A, Hugh T, Aldrighetti L, Shen F, Koerkamp BG, Endo I, Pawlik TM. The complication-overall survival (CompOS) risk tool predicts risk of a severe postoperative complications relative to long-term survival among patients with primary liver cancer. J Gastrointest Surg. 2024 02; 28(2):132-140.
    View in: PubMed
    Score: 0.157
  30. Tsilimigras DI, Endo Y, Ratti F, Marques HP, Cauchy F, Lam V, Poultsides GA, Popescu I, Alexandrescu S, Martel G, Kitago M, Guglielmi A, Hugh T, Aldrighetti L, Gleisner A, Shen F, Endo I, Pawlik TM. Perioperative Lymphopenia is Associated with Increased Risk of Recurrence and Worse Survival Following Hepatectomy for Hepatocellular Carcinoma. Ann Surg Oncol. 2024 Apr; 31(4):2568-2578.
    View in: PubMed
    Score: 0.156
  31. Tsilimigras DI, Endo Y, Ratti F, Marques HP, Cauchy F, Lam V, Poultsides GA, Popescu I, Alexandrescu S, Martel G, Kitago M, Guglielmi A, Hugh T, Aldrighetti L, Gleisner A, Shen F, Endo I, Pawlik TM. The aMAP score predicts long-term outcomes after resection of hepatocellular carcinoma: a multi-institutional analysis. HPB (Oxford). 2024 04; 26(4):541-547.
    View in: PubMed
    Score: 0.156
  32. Resende V, Tsilimigras DI, Endo Y, Guglielmi A, Ratti F, Aldrighetti L, Marques HP, Soubrane O, Lam V, Poultsides GA, Popescu I, Alexandrescu S, Gleisner A, Martel G, Hugh T, Endo I, Shen F, Pawlik TM. Machine-Based Learning Hierarchical Cluster Analysis: Sex-Based Differences in Prognosis Following Resection of Hepatocellular Carcinoma. World J Surg. 2023 12; 47(12):3319-3327.
    View in: PubMed
    Score: 0.153
  33. Endo Y, Moazzam Z, Alaimo L, Woldesenbet S, Lima HA, Munir MM, Katayama E, Yang J, Azap L, Shaikh CF, Ratti F, Marques HP, Cauchy F, Lam V, Poultsides GA, Kitago M, Popescu I, Alexandrescu S, Martel G, Guglielmi A, Gleisner A, Hugh T, Aldrighetti L, Shen F, Endo I, Pawlik TM. Modified integrated tumor burden, liver function, systemic inflammation, and tumor biology score to predict long-term outcomes after resection for hepatocellular carcinoma. HPB (Oxford). 2023 12; 25(12):1484-1493.
    View in: PubMed
    Score: 0.151
  34. Endo Y, Munir MM, Woldesenbet S, Katayama E, Ratti F, Marques HP, Cauchy F, Lam V, Poultsides GA, Kitago M, Popescu I, Alexandrescu S, Martel G, Workneh A, Guglielmi A, Gleisner A, Hugh T, Aldrighetti L, Shen F, Endo I, Pawlik TM. Impact of Surgical Margin Width on Prognosis Following Resection of Hepatocellular Carcinoma Varies on the Basis of Preoperative Alpha-Feto Protein and Tumor Burden Score. Ann Surg Oncol. 2023 Oct; 30(11):6581-6589.
    View in: PubMed
    Score: 0.150
  35. Chapman BC, Paniccia A, Hosokawa PW, Henderson WG, Overbey DM, Messersmith W, McCarter MD, Gleisner A, Edil BH, Schulick RD, Gajdos C. Impact of Facility Type and Surgical Volume on 10-Year Survival in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma. J Am Coll Surg. 2017 Mar; 224(3):362-372.
    View in: PubMed
    Score: 0.095
  36. Brandão A, Fuchs SC, Gleisner AL, Marroni C, Zanotelli ML, Cantisani G. MELD and other predictors of survival after liver transplantation. Clin Transplant. 2009 Mar-Apr; 23(2):220-7.
    View in: PubMed
    Score: 0.055
  37. Pawlik TM, Gleisner AL, Anders RA, Assumpcao L, Maley W, Choti MA. Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implications for transplant eligibility. Ann Surg. 2007 Mar; 245(3):435-42.
    View in: PubMed
    Score: 0.048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)